Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 12
1992 15
1993 16
1994 26
1995 31
1996 33
1997 32
1998 22
1999 33
2000 51
2001 31
2002 39
2003 59
2004 49
2005 54
2006 59
2007 61
2008 76
2009 79
2010 94
2011 136
2012 117
2013 123
2014 139
2015 128
2016 115
2017 114
2018 137
2019 98
2020 171
2021 121
2022 34
2023 7
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

2,066 results

Results by year

Filters applied: . Clear all
Page 1
Interleukin-6 in Rheumatoid Arthritis.
Pandolfi F, Franza L, Carusi V, Altamura S, Andriollo G, Nucera E. Pandolfi F, et al. Int J Mol Sci. 2020 Jul 23;21(15):5238. doi: 10.3390/ijms21155238. Int J Mol Sci. 2020. PMID: 32718086 Free PMC article. Review.
Overview of Castleman disease.
Dispenzieri A, Fajgenbaum DC. Dispenzieri A, et al. Blood. 2020 Apr 16;135(16):1353-1364. doi: 10.1182/blood.2019000931. Blood. 2020. PMID: 32106302 Free article. Review.
Translating IL-6 biology into effective treatments.
Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T. Choy EH, et al. Nat Rev Rheumatol. 2020 Jun;16(6):335-345. doi: 10.1038/s41584-020-0419-z. Epub 2020 Apr 23. Nat Rev Rheumatol. 2020. PMID: 32327746 Free PMC article. Review.
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez-Cruz A, Feuth T, Garcia F, Garcia-Vicuna R, Gonzalez-Alvaro I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, Landray MJ, Leal L, Lederer DJ, Lorenzi E, Mariette X, Merchante N, Misnan NA, Mohan SV, Nivens MC, Oksi J, Perez-Molina JA, Pizov R, Porcher R, Postma S, Rajasuriar R, Ramanan AV, Ravaud P, Reid PD, Rutgers A, Sancho-Lopez A, Seto TB, Sivapalasingam S, Soin AS, Staplin N, Stone JH, Strohbehn GW, Sunden-Cullberg J, Torre-Cisneros J, Tsai LW, van Hoogstraten H, van Meerten T, Veiga VC, Westerweel PE, Murthy S, Diaz JV, Marshall JC, Sterne JAC. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, et al. JAMA. 2021 Aug 10;326(6):499-518. doi: 10.1001/jama.2021.11330. JAMA. 2021. PMID: 34228774 Free PMC article.
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
Spiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B; SAPHYR Investigators. Spiera RF, et al. N Engl J Med. 2023 Oct 5;389(14):1263-1272. doi: 10.1056/NEJMoa2303452. N Engl J Med. 2023. PMID: 37792612 Clinical Trial.
2,066 results